Evidence map›Paper›PMID 26325356›Full record

Observational studyAnnals of the American Thoracic Society2015

Exogenous Reinfection as a Cause of Late Recurrent Tuberculosis in the United States.

Julia D Interrante, Maryam B Haddad, Lindsay Kim, Neel R Gandhi

Open access · greenAbstract readObservational Study
In one paragraph

Observational study in Annals of the American Thoracic Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Recurrent tuberculosis in the Netherlands - a 24-year follow-up study, 1993 to 2016.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2022
    Article
  4. High Rates of Recurrent Tuberculosis Disease: A Population-level Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  5. Relapse or Re-Infection, the Situation of Recurrent Tuberculosis in Eastern China.Frontiers in cellular and infection microbiology · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Antigenic Variation and Immune Escape in the MTBC.Advances in experimental medicine and biology · 2017
    Review
  14. Reply: Missing Stowaways and Lack of Expected Concurrent Infections.Annals of the American Thoracic Society · 2015
    Article
  15. Infection of multipleInternational journal of mycobacteriology
    Article
  16. Tuberculosis treatment.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
    Review
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Julia D Interrante1 Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia; and.
Maryam B Haddad1 Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia; and.
Lindsay Kim1 Division of Tuberculosis Elimination, Centers for Disease Control and Prevention, Atlanta, Georgia; and.
Neel R Gandhi2 Department of Epidemiology.
National Institute of Epidemiology · INCenters for Disease Control and Prevention · USMRC Epidemiology Unit · GB

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Impact of HIV, Antiretroviral Therapy and TB Genotype on Survival in MDR TBR01AI087465 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.9M
Transmission of HIV-Associated XDR TB in Rural South AfricaR01AI089349 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2010 to 2014
$3.7M
Mentorship in Patient-Oriented Research in Tuberculosis, HIV and Global HealthK24AI114444 · NIAID · EMORY UNIVERSITY · PI GANDHI, NEEL RAJNIKANT · 2014 to 2023
$1.8M
NIAID NIH HHS K24 AI114444NIAID NIH HHS K24AI114444NIAID NIH HHS P30 AI050409NIAID NIH HHS R01 AI087465NIAID NIH HHS R01 AI089349
6 · The paper itself

Abstract

rationaleThe etiology of recurrent tuberculosis is typically presumed to be reactivation of residual Mycobacterium tuberculosis infection, but reinfection may account for a greater proportion of recurrent tuberculosis than previously recognized.

objectiveTo use M. tuberculosis genotyping to characterize the etiology of recurrent tuberculosis occurring 12 months or more after treatment completion.

methodsThe study population for this national population-based cohort was drawn from the estimated 3,039 persons reported to the National Tuberculosis Surveillance System with two episodes of tuberculosis in the United States during 1993-2011, 194 of whom had genotyping results from both the initial and subsequent episode. We analyzed the proportion of recurrent tuberculosis attributable to and risk factors associated with reinfection. MEASUREMENTS AND MAIN

resultsAmong 136 recurrences meeting inclusion criteria, genotypes between episodes were the same for 116 (85%) recurrences during 1996-2011; the 20 (15%) with differing genotypes were categorized as reinfections. Using exact logistic regression, factors associated with reinfection included Mexican birth with both TB episodes diagnosed in the United States within 12 years of immigration (adjusted odds ratio, 10.7; 95% confidence interval, 1.7-86.3) and exclusive use of directly observed therapy for treatment of the first episode (adjusted odds ratio, 4.5; 95% confidence interval, 1.0-29.2).

conclusionsReinfection was the cause of 15% of late recurrent tuberculosis cases in this U.S. cohort. The proportion caused by reinfection increased to 60% in certain subpopulations, such as recent immigrants from Mexico, suggesting that, despite successful treatment for tuberculosis during their first episode, these individuals remain in a social environment where they are reexposed to M. tuberculosis. Public health interventions to prevent novel reinfection might require a broader focus in these communities.

Indexed as

AdultEmigrants and ImmigrantsFemaleGenotypeHumansLogistic ModelsMaleMexicoMiddle AgedMycobacterium tuberculosisRecurrenceRetrospective StudiesRisk FactorsTuberculosisUnited Statesemigration and immigrationepidemiologymolecular epidemiologyMycobacteriumrisk factors

Identifiers

PMID26325356
PMCPMC4724895
OpenAlexW2102942644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.